CORE
🇺🇦
make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Four-Year Follow-up of the Phase 3 Pollux Study of Daratumumab Plus Lenalidomide and Dexamethasone (D-Rd) Versus Lenalidomide and Dexamethasone (Rd) Alone in Relapsed or Refractory Multiple Myeloma (RRMM)
Authors
Jonathan L. Kaufman Usmani, Saad Z. San-Miguel, Jesus and Bahlis, Nizar White, Darrell J. Benboubker, Lotfi Cook, Gordon Leiba, Merav Ho, P. Joy Kim, Kihyun Takezako, Naoki Moreau, Philippe Krevvata, Maria Pei, Huiling and Ukropec, Jon Renaud, Thomas Trivedi, Sonali Kobos, Rachel and Dimopoulos, Meletios A.
Publication date
1 January 2019
Publisher
Abstract
Abstract is not available.
Similar works
Full text
Available Versions
Pergamos : Unified Institutional Repository / Digital Library Platform of the National and Kapodistrian University of Athens
See this paper in CORE
Go to the repository landing page
Download from data provider
oai:lib.uoa.gr:uoadl:3187680
Last time updated on 10/02/2023
